AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2025
Apr 1, 2025
33510_dirs_2025-04-01_7d0eef40-b447-430f-9b1c-a5c3aa5ae2f0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Perspective Therapeutics, Inc. (CATX)
CIK: 0000728387
Period of Report: 2025-03-31
Reporting Person: Woods Lori A (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-31 | Common Stock | P | 23475 | $2.1299 | Acquired | 183460 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4807 | Direct |
More from Perspective Therapeutics, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16